# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126296
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:30
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ck0001534133-20240930.htm iXBRL | 10-Q | 2594614
2 | EX-31.1 | ck0001534133-ex31_1.htm | EX-31.1 | 15164
3 | EX-31.2 | ck0001534133-ex31_2.htm | EX-31.2 | 15411
4 | EX-32.1 | ck0001534133-ex32_1.htm | EX-32.1 | 9743
5 | EX-32.2 | ck0001534133-ex32_2.htm | EX-32.2 | 9125
| Complete submission text file | 0000950170-24-126296.txt |  | 9219892

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ck0001534133-20240930.xsd | EX-101.SCH | 1299378
66 | EXTRACTED XBRL INSTANCE DOCUMENT | ck0001534133-20240930_htm.xml | XML | 1380341

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39538 | Film No.: 241454052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)